Revised: April 2026
The Journal of Korean Academy of Nursing Administration (JKANA) is the official journal of the Korean Academy of Nursing Administration and is published five times a year (regular issues on March 31, June 30, September 30, and December 31, and a special issue on January 31). The journal publishes research that contributes to the advancement of nursing science. Articles include studies related to nursing practice, nursing education, nursing administration, and health policy; studies addressing health issues related to nursing; and studies that examine the practical application of research findings. Manuscripts submitted to the Journal shall be prepared specifically for the Korean Academy of Nursing Administration.
All studies involving human or animal subjects shall state in the Methods section whether the study was reviewed and approved by the relevant ethics committee (Institutional Review Board [IRB], where applicable) and shall provide the approval number. Manuscripts containing research misconduct, such as falsification, fabrication, or plagiarism, in the reporting of research results may be rejected following review by the Ethics Committee. Any conflicts of interest shall be disclosed. All persons listed as authors shall have participated sufficiently in the research to take public responsibility for the content of the manuscript. Detailed matters concerning research ethics shall be governed by the Journal’s Research and Publication Ethics Policy and the ethics-related provisions of the Submission and Publication Policy.
At submission, authors must disclose on the title page whether artificial intelligence (AI)-assisted technologies, such as large language models (LLMs), chatbots, or image generation tools, were used in preparing the manuscript. If AI tools were used, their purpose and manner of use should be described in the appropriate section of the manuscript according to how they were used. If AI was used for language editing, this should be stated in the Acknowledgements section. If AI was used in research procedures, such as data collection, processing, analysis, or the generation of images or tables, this should be described in detail in the Methods section. Any other use should be disclosed in an appropriate section of the manuscript according to the type of AI tool and its purpose. AI and AI-assisted technologies may not be listed as an author or co-author, nor cited as an author. All legal and ethical responsibility for the submitted materials, including their accuracy, integrity, originality, and proper citation, rests solely with the human authors.
Members of the Korean Academy of Nursing Administration may submit manuscripts. The first author and the corresponding author must be full members of the Academy. However, this requirement shall not apply to authors affiliated with institutions outside Korea.
JKANA follows the recommendations for authorship set out by the ICMJE (2026) (https://www.icmje.org/icmje-recommendations.pdf). Authorship credit should be based on the following: 1) substantial contributions to the conception or design of the work, or to the acquisition, analysis, or interpretation of data for the work; 2) drafting the work or reviewing it critically for important intellectual content; 3) final approval of the version to be published; and 4) agreement to be accountable for all aspects of the work to ensure that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Any designated author should meet all four criteria for authorship, and anyone who meets all four criteria should be identified as an author. The authors have confidence in the integrity of the contributions of their coauthors. All other contributors not listed as authors should be mentioned in the Acknowledgements section. When a master’s thesis or doctoral dissertation is submitted for publication, the first author should be awarded the degree and declare that the content is from the thesis or dissertation.
The corresponding author is the author who takes responsibility for the entire manuscript submission process. The corresponding author determines the inclusion of co-authors and the order of authorship. The corresponding author must circulate the final manuscript to all co-authors and notify them of the submission in order to obtain their confirmation. If revision is required after peer review, the corresponding author must also inform all co-authors and obtain their approval. At the time of submission, all authors must provide their ORCID iD, which can be created at https://orcid.org.
Any addition, deletion, or rearrangement of author names in the authorship list may be made prior to the initiation of peer review. Any changes thereafter require prior approval by the Editorial Board before a final decision is made on the manuscript. To request such a change, the corresponding author must submit the following to the Editorial Board: (a) the reason(s) for the change in the author list; (b) written confirmation from all authors that they agree to any addition, removal, or rearrangement of author names; and (c) reasonable supporting documentation. If the manuscript has already been published online, any such request will be decided upon through discussion by the Editorial Board, and all approved changes will be published in a corrigendum.
Co-first authorship and co-corresponding authorship are, in principle, not permitted. Only one corresponding author may be designated, and the corresponding author assumes full responsibility for all aspects of the manuscript, including its content, peer review, and publication.
The following types of articles may be published in the journal. Manuscripts should be prepared in accordance with established reporting guidelines appropriate to the study design. A collection of reporting guidelines by study design is available at http://www.equator-network.org
Observational cohort, case-control and cross-sectional studies
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)
Meta-analysis of Observational Studies in Epidemiology (MOOSE)
Qualitative studies
Consolidated Criteria for Reporting Qualitative Research (COREQ)
Standards for Reporting Qualitative Research (SRQR)
Quasi-experimental/ non-randomized trials
Transparent Reporting of Evaluations with Non-randomized Designs (TREND)
Randomized (and quasi randomized) controlled trials
Consolidated Standards of Reporting Trials (CONSORT)
Study of Diagnostic accuracy/assessment scale
Standards for the Reporting of Diagnostic Accuracy Studies (STARD)
Systematic Review and meta-analysis
Preferred Reporting Items for Systematic Reviews and Meta Analyses (PRISMA)
Meta-analysis of Observational Studies in Epidemiology (MOOSE)
Quality improvement studies
Standards for Quality Improvement Reporting Excellence (SQUIRE)
Manuscripts may be written in Korean or English. Manuscripts should be prepared on A4 paper with margins of 30 mm at the top and 25 mm at the bottom, left, and right. The text should be formatted in Shinmyeongjo or Times New Roman font, 10-point size, with 200% line spacing. Page numbers should appear at the bottom of each page. The manuscript should not exceed 20 pages, including tables, figures, and references. The manuscript should be organized in the following order: title page, abstract and keywords, main text, references, tables, and figures. Abbreviations, drug names, references, tables, and figures should be prepared in accordance with the National Library of Medicine (NLM) style (http://www.nlm.nih.gov/citingmedicine).
Title Page
As this journal employs a double-blind peer review process, identifying information such as the authors’ names and institutional affiliations should be included only on the title page. The title page must follow the prescribed format and should include the following:
Abstract and Keywords
The abstract should be written in English and presented on a separate page. It should not exceed 200 words. The abstract should be structured under the headings Purpose, Methods, Results, and Conclusion, and written as a single paragraph without line breaks, within 200 words excluding the title and author names. Up to five English keywords that reflect the content of the manuscript should be provided immediately after the abstract. In principle, keywords should be selected from the Medical Subject Headings (MeSH) Browser (www.nlm.nih.gov/mesh/MBrowser.html), although additional keywords relevant to the study topic may also be used.
Main Text
Tables, Figures, and Photographs
References
References must be accurate and complete. Authors are responsible for the accuracy of references and for ensuring consistency between in-text citations and the reference list.
In-text Citations
Reference List
All submitted manuscripts undergo peer review by experts in the relevant field. Each manuscript is reviewed by two reviewers, and decisions are made as follows: accept, minor revision, major revision, or reject. If necessary, an additional review may be requested from a third reviewer. The final decision on publication is made by the Editor-in-Chief. Detailed procedures and criteria for peer review are governed by a separate Peer Review Policy.
A review fee of KRW 40,000 per manuscript is charged, and peer review begins only after payment of the review fee. For accepted manuscripts, the corresponding author is required to pay a publication fee of KRW 50,000 per page for proofreading, English editing, and journal production.
Copyright and transfer right of the content of all published papers and the journal is owned by the Korean Academy of Nursing Administration.
Authors should submit manuscripts through the online submission system (https://submit.jkana.or.kr/). During the submission process, all authors must complete and submit a manuscript checklist together with the manuscript to confirm that the basic requirements for submission have been met. At the time of submission, the corresponding author must also submit, through the online submission system, a consent form signed by all authors regarding copyright transfer and disclosure of conflicts of interest.
After a manuscript has been accepted for publication, the galley proof will be sent to the corresponding author. The corresponding author must review the proof for typographical errors, formatting errors, and any omissions of tables and figures. Major changes, such as additions to or revisions of the content, are not permitted at this stage. The corrected proof must be returned to the Editorial Board within the designated period. The author is responsible for any problems caused by delays in returning the proof and for any errors not identified during the proofreading process.